At a Glance
Dosage
Only in 3,4-CTMP
oral
| Level | Dose |
|---|---|
| Threshold | 2 mg |
| Light | 2–4 mg |
| Common | 4–6 mg |
| Strong | 6–8 mg |
| Heavy | 8 mg |
Only in 2-FEA
insufflated
| Level | Dose |
|---|---|
| Threshold | 15 mg |
| Light | 20–30 mg |
| Common | 30–40 mg |
| Strong | 40–60 |
Duration
Only in 3,4-CTMP
oral
Total: 6 hrs – 18 hrsAfterglow
Onset1 hrs – 2 hrs
Afterglow2 hrs – 24 hrs
Only in 2-FEA
insufflated
Total: 1 hrs – 2.5 hrsPeak
Offset
Effects
Safety
Interaction: 3,4-CTMP + 2-FEA
No direct interaction data available between these substances. This does not mean the combination is safe.
3,4-CTMP — Dangerous Interactions
2-FEA — Dangerous Interactions
Frequently Asked Questions
What is the difference between 3,4-CTMP and 2-FEA?
3,4-CTMP is classified as a Stimulants (Substituted phenidates) while 2-FEA is classified as a Entactogen, Stimulants (Substituted amphetamines). They share 35 effects in common, with 9 effects unique to 3,4-CTMP and 21 unique to 2-FEA.
Is it safe to combine 3,4-CTMP and 2-FEA?
There is no direct interaction data available for combining 3,4-CTMP and 2-FEA. This does not mean the combination is safe. Always exercise caution and research thoroughly.
Which is stronger, 3,4-CTMP or 2-FEA?
3,4-CTMP and 2-FEA are typically administered via different routes, making a direct potency comparison difficult. They belong to different pharmacological profiles and should not be compared by dose alone.